Skip to content
NeuroView Technology
News & Publications
Press Release2 min read

NeuroView receives NIH Blueprint MedTech seedling grant

The National Institutes of Health program selects NeuroView to support research on nervous system monitoring technology.

By NeuroView Communications

The award

NeuroView has been selected as an awardee of a seedling grant from the National Institutes of Health Blueprint MedTech program. The award supports research on continuous nervous system monitoring technology, providing funding and access to NIH research resources.

NIH Blueprint MedTech

The NIH Blueprint MedTech program is a cross-institute initiative designed to spur innovation in diagnosing and treating nervous system disorders. By pooling resources across multiple NIH institutes, it supports transformative neuroscience research and the development of new tools for neuroscientists.

  • Seedling grants support early-stage development of high-potential neurotechnology.
  • Awardees gain access to NIH facilities, expertise, and regulatory guidance.
  • The program focuses on tools that address unmet needs in nervous system diagnosis and therapy.
  • Blueprint pools resources from more than ten NIH institutes.

Frequently asked questions

What is the NIH Blueprint MedTech program?

A cross-institute NIH initiative that funds innovation in diagnosing and treating nervous system disorders, pooling resources across more than ten institutes.

What does the grant support?

Research on NeuroView's continuous nervous system monitoring technology, with funding and access to NIH resources.

More from NeuroView